SHELLEY CAMPBELL: Open Payments
NPI 1316502750 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$82 in 5 payments from 4 companies in 2025. Trend: 2023 $158 · 2024 $294 · 2025 $82
Food & beverage: $82
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Astellas Pharma US Inc | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: Veozah, Rybelsus, ZORYVE, FARXIGA, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
